<<<<<<< HEAD
# Public Research Module 3 Report

## Authors

- **Patricia Honorato Moreira** â€“ Student (Inteli)  
- **Flavia Santoro** â€“ Co-advisor, (Inteli)
- **Luciana Rodrigues Carvalho Barros** â€“ Supervisor (FundaÃ§Ã£o Faculdade de Medicina)  
- **Roger Chammas** â€“ Co-supervisor (Hospital das ClÃ­nicas da Faculdade de Medicina da Universidade de SÃ£o Paulo â€“ HCFMUSP)

---
## Research Area

This research focuses on the development of **interpretable and clinically applicable machine learning models** to predict **recurrence and survival outcomes** in breast cancer patients.  
The models are designed according to **TRIPOD** reporting guidelines and integrate clinical and hematological data to enhance prognostic accuracy.  

In this module, the project transitioned to a new scope, expanding the analysis from a single **10-year recurrence horizon** to a **multi-horizon framework** that evaluates recurrence at **2, 5, and 10 years**.  
This pivot required manuscript restructuring, reformatted figures, and new modeling preparation steps for the next module.

---

## Overview of Sprints

### Sprint 1
**Objective:** Establish target journal and produce the initial full manuscript draft.  
**Activities:**
- Authored the **complete raw manuscript** (Introduction, Methods, Results, Discussion, Conclusions).  
- Defined the **target journal** (*Cancer Research â€“ AACR*) and publication window (**December 2025**).  
- Outlined **format constraints** (â‰¤250-word abstract, â‰¤5,000-word text, â‰¤8 display items, â‰¤50 references).  
- Re-scoped the module to prioritize **writing and formatting** before adding new analyses.

**Outcome:**  
A comprehensive unformatted manuscript draft was completed and serves as the foundation for subsequent revisions.

---

### Sprint 2
**Objective:** Advance manuscript structure and build reproducible model artifacts per tumor subtype.  
**Activities:**
- Wrote the **Introduction**, **Abstract**, and **Statement of Significance** following *Cancer Research* requirements.  
- Developed **three Jupyter notebooks per subtype** (HR+, HER2+, TNBC):  
  1. Data Preparation  
  2. Model Development  
  3. Model Evaluation  
- Implemented metrics (AUC, AUPR, calibration) and explainability (SHAP).  
- Version-controlled all notebooks in GitHub and mirrored to cloud storage.

**Outcome:**  
A structured and transparent modeling framework was established for each subtype.

---

### Sprint 3
**Objective:** Expand the manuscript with detailed Methods and Results sections.  
**Activities:**
- Authored the full **Methods** section, describing:
  - Cohort selection, ethical compliance, and preprocessing workflow.  
  - Feature engineering (e.g., NLR, PLR, MLR ratios, PCA/UMAP/GMM latent features).  
  - Modeling strategies (Random Forest, XGBoost, SVM, and Stacked Ensemble).  
  - Validation procedures and performance metrics.  
- Wrote **Results** describing:
  - Subtype-specific model performance (AUC ~0.75â€“0.85).  
  - Feature selection workflow and Kaplanâ€“Meier survival stratification.

**Outcome:**  
The manuscript achieved full technical completeness and methodological transparency.

---

### Sprint 4
**Objective:** Refine manuscript text, prepare figures, and organize expanded dataset.  
**Activities:**
- Rewrote and refined **Discussion** for clarity and coherence.  
- Standardized **figure legends** for all panels:  
  - **Figure 1:** Workflow and modeling pipeline.  
  - **Figure 2:** Clinical and hematologic features table.  
  - **Figures 3â€“6:** ROC curves for general and subtype-specific models (HR+, HER2+, TNBC).  
- Conducted **dataset expansion (+200 patients)** for the general model, including data validation.  
- Reformatted and documented **Jupyter notebooks** for public release:  
  - Subtype-specific models and **general recurrence model (â‰¤10 years)**.  
  - Added a **dedicated notebook for early recurrence (â‰¤2 years)**.  
- Planned integration of updated results in the next sprint.

**Outcome:**  
The manuscript and datasets were technically prepared for the upcoming pivot in modeling scope.

---

### Sprint 5
**Objective:** Prepare the transition to multi-horizon modeling (2-, 5-, and 10-year recurrence) and reformat project notebooks for publication.  
**Activities:**
- Defined a **new modeling objective** to handle recurrence at **multiple time windows** (2, 5, 10 years).  
- Revised the **manuscript structure and placeholders** to reflect the new scope.  
- Reformatted and standardized all **notebooks** for clarity, modularity, and publication readiness:
  - General and subtype-specific models (HR+, HER2+, TNBC) for up to 10 years.  
  - Added an **â€œearly recurrenceâ€ notebook (â‰¤2 years)**.  
- Adjusted the **data pipeline** and labeling functions to support multi-horizon recurrence modeling.  
- Verified data consistency across time horizons.  
- Drafted internal notes on the reorganization of figures and the Discussion section for the next module.

**Note:**  
- The **manuscript is still a working draft**, pending review by all collaborators.  
- The **figures and discussion sections are incomplete** and will be rewritten in the next module (Module 4).  
- **SMOTE analyses and final metrics have not yet been conducted**.

**Outcome:**  
The sprint established the methodological and organizational foundation for the multi-horizon models that will be developed in the next phase.

---

## Project Status

| Component | Status | Notes |
|------------|---------|-------|
| **Dataset** | âœ… Ready | Includes recurrence labels for 2-, 5-, and 10-year horizons. |
| **Notebooks (General + Subtypes + Early Recurrence)** | âœ… Reformatted | Modularized and documented for publication. |
| **Manuscript** | ðŸŸ¡ In progress | Text revised to reflect new modeling scope; not yet finalized. |
| **Figures & Discussion** | âš ï¸ Incomplete | Will be rewritten after new model analyses in Module 4. |
| **SMOTE Analyses** | â³ Pending | To be conducted after retraining models for all time horizons. |
| **Team Review** | â³ Pending | Manuscript to undergo full revision by all collaborators. |

---

## Conclusions

Module 3 marked a significant **pivot in project direction**, shifting from single-horizon (10-year) modeling to a **multi-horizon recurrence framework (2, 5, and 10 years)**.  
Key outcomes include:
- Reformatted and standardized notebooks for transparency and publication.  
- Dataset preparation and labeling for time-window modeling.  
- Revised manuscript structure aligned with the new analytical goals.  
- Technical groundwork completed for final model development and manuscript completion in the next module.

Although the manuscript and figures remain incomplete, the project is now strategically positioned for the **Finalization Phase (Module 4)**, where analyses and writing will converge toward submission readiness.

---

## Next Steps (Module 4 â€“ Finalization Phase)

- Train and evaluate models for **2, 5, and 10-year recurrence horizons**.  
- Conduct **SMOTE and cross-validation analyses** across general and subtype models.  
- Regenerate **figures and tables** for all time horizons.  
- Rewrite the **Discussion** to integrate new results and clinical interpretation.  
- Finalize **References** and perform complete formatting check.  
- Submit for **team-wide review** prior to journal submission.

---

## Acknowledgments

This project is developed in collaboration between **Inteli â€“ Instituto de Tecnologia e LideranÃ§a**, **FundaÃ§Ã£o Faculdade de Medicina**, and **Hospital das ClÃ­nicas da Faculdade de Medicina da Universidade de SÃ£o Paulo (HCFMUSP)**.  
We thank the supervisors and data management teams for their continued support and technical contributions.

---


*Report Version:* Public Module 3 Report  
*Date:* October 2025  
*Prepared by:* **Patricia Honorato Moreira**  
*Supervised by:* **Luciana R. C. Barros**, **Flavia Santoro**, **Roger Chammas**  
=======
# Public Research Module 2 Report
## Authors:

- Patricia Honorato Moreira â€“ Student (Inteli)
  
- Jefferson Silva â€“ Co-supervisor (Inteli)
  
- Luciana Rodrigues Carvalho Barros â€“ Supervisor (FundaÃ§Ã£o Faculdade de Medicina)
  
- Roger Chammas â€“ Co-supervisor (Hospital das ClÃ­nicas da Faculdade de Medicina da Universidade de SÃ£o Paulo - HCFMUSP)

## Research Area

This project focuses on developing interpretable and clinically applicable machine learning models to predict 10-year recurrence or death in breast cancer patients. The work follows TRIPOD reporting standards and leverages clinical and laboratory data to enhance prognostic accuracy.

---

## Overview of Sprints

### Sprint 1
**Objective:** Initiate scientific communication materials and establish manuscript structure.  
**Activities:**
- Designed a scientific poster summarizing project objectives, methodology, and preliminary results for conference presentation.
- Drafted the Introduction section of the manuscript, including clinical background, project motivation, and study aims.
- Defined the full manuscript structure to align with academic publication standards.
- Generated initial visualizations for poster and manuscript figures (laboratory marker distributions, prognostic ratios).

---

### Sprint 2
**Objective:** Develop the general predictive model and document technical methodology.  
**Activities:**
- Completed Methods and Results sections describing the full analytical pipeline (cohort selection to model interpretation).
- Developed a general predictive model using Random Forest, XGBoost, SVM, and Stacked Ensemble methods based on pre-treatment lab data.
- Applied SMOTE to correct class imbalance; evaluated performance via AUC, precision, recall, and SHAP interpretability.
- Conducted preliminary Kaplanâ€“Meier survival analysis stratifying patients by predicted risk.
  
**Note:** Subtype-specific models postponed due to pending tumor subtype data access.

---

### Sprint 3
**Objective:** Refine manuscript drafts and enhance modeling reproducibility.  
**Activities:**
- Completed first draft of the Results section, integrating:
  - Performance metrics and confidence intervals.
  - SHAP analysis for model interpretability.
  - Survival analysis by predicted risk groups.
- Organized project notebooks for clarity and reproducibility:
  - **Notebook 1:** Data preparation, exploratory analysis, feature engineering.
  - **Notebook 2:** Model training, feature selection, hyperparameter tuning, evaluation structure.
- Ensured modeling pipeline alignment with TRIPOD guidelines for transparent reporting.

---

### Sprint 4
**Objective:** Contextualize results and draft the Discussion section.  
**Activities:**
- Completed first version of the Discussion section addressing:
  - Performance and stability of the stacked ensemble model (ROC-AUC ~0.82â€“0.83).
  - Comparisons with existing prognostic tools.
  - Alignment of model interpretability with clinical expertise (tumor staging, inflammatory biomarkers).
  - Clinical applicability in resource-limited settings.
  - Study limitations (single-center data, need for external validation).

---

### Sprint 5
**Objective:** Consolidate evaluation, interpretability, and survival analyses in a unified notebook; draft article abstract.  
**Activities:**
- Combined evaluation components into one comprehensive notebook, including:
  - Performance metrics for all models (Random Forest, XGBoost, SVM, Stacking): AUC, accuracy, precision, recall.
  - ROC curves for individual models and combined performance comparison.
  - Global feature importance (Random Forest, XGBoost).
  - SHAP interpretability analysis.
  - Kaplanâ€“Meier survival analysis by risk groups.
- Drafted scientific abstract summarizing methodology, key results, and clinical relevance.

---

## Project Status

- Major manuscript sections (Introduction, Methods, Results, Discussion, Abstract) prepared but not finalized.
- Completing the manuscript for submission remains a priority for the next module.

---

## Conclusions

- Module 2 delivered substantial progress in:
  - General model development.
  - Interpretability analyses (SHAP, feature importance).
  - Survival stratification (Kaplanâ€“Meier).
  - Manuscript drafting.
- Foundations are in place for:
  - Subtype-specific models.
  - External validation.
  - Scientific dissemination.

---

## Next Steps

- Finalize the complete article manuscript for peer-reviewed journal submission.
- Develop and evaluate prognostic models for specific tumor subtypes.
- Perform additional exploratory analyses (PCA, UMAP) to characterize data structure if needed for publication.
- Enhance reproducibility, technical documentation, and figure quality to meet publication standards.

---

## Notes

This public report summarizes activities within the clinical predictive modeling field for oncology, ensuring confidentiality of sensitive data and internal project details.
>>>>>>> 24d9ab9bb1489bdd7c48defff4ce7dc7b7837af3
